Ustekinumab-Ttwe 82009-0163-94

Package NDC

82009-0163-94

Product NDC: 82009-0163

Manufacturer: Quallent Pharmaceuticals Health Llc
Dosage Form: Injection, Solution
Route: Intravenous
Product Type: Human Prescription Drug
Marketing Start: April 15, 2025
Listing Expires: December 31, 2027
Application: BLA761425

Need to source Ustekinumab-Ttwe? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Ustekinumab	130 mg/26mL

Drug Class

Interleukin-12 Antagonist [EPC]Interleukin-23 Antagonist [EPC]Interleukin-12 Antagonist [EPC]

Selected Package

82009-0163-94Selected

1 VIAL, SINGLE-USE in 1 CARTON (82009-163-94) / 26 mL in 1 VIAL, SINGLE-USE